About 100 reports

  • CANCER GENE THERAPY IN AMERICAS
  • High cost of gene therapy treatment
  • Biological Therapy
  • Cancer Gene Therapy
  • Gene Therapy
  • China
  • Celgene Corporation

Global Gene Therapy Market ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Market Size
  • European Cell and Gene Therapies Market
  • European Cell and Gene Therapies Market
  • Gene Therapy
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Gene Therapy
  • Gene Therapy Sales and Forecasts (Billion Yuan)
  • Gene Therapy
  • Healthcare
  • Therapy
  • China
  • Demand

Europe Cancer gene therapy Market by Therapy ##. ##.

  • Biological Therapy
  • Cancer Gene Therapy
  • Gene Therapy
  • Market Size
  • 9.7 BENITEC BIOPHARMA LTD
  • 7.4 REST OF THE WORLD
  • Gene Therapy
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics, Inc.
  • QIAGEN N.V.
  • Sirna Therapeutics, Inc.
  • GENE THERAPY FOR METASTATIC BREAST CANCER
  • GENE THERAPY FOR HEPATITIS B AND HEPATITIS C
  • Blood Disease
  • Gene Therapy
  • Recombinant Protein
  • Therapy
  • Supply
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA A
  • Gene Therapy
  • United States
  • Alnylam Pharmaceuticals, Inc.
  • Pharming Group NV
  • uniQure N.V.

Survey data from ## researchers involved in gene therapy Companies profiled: uniQure, Voyager Therapeutics, Oxford BioMedica, GeneQuine Therapeutics, Celladon Corporation, and bluebird Topics covered: Development of improved vectors (integrating and non-integrating vectors)

  • Biological Therapy
  • Gene Therapy

MARKET OVERVIEW.............. ## Gene Therapy.............. ## Table ##: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins,

  • Gene Therapy
  • Genomics
  • World
  • Market Shares
  • Market Size
  • GENE THERAPY VECTORS: DOSAGE FREQUENCY
  • OPEN GENE THERAPY TRIALS: DISTRIBUTION BY PHASE OF DEVELOPMENT
  • Gene Therapy
  • United States
  • Market Size
  • MolMed S.p.A.
  • uniQure N.V.

High cost associated with gene therapies ##. ##. ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Viral Vector
  • Market Size
  • MARKETED CELL / GENE THERAPIES: PRICE
  • CELL THERAPY MANUFACTURING: CONTRACT MANUFACTURERS
  • Gene Therapy
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • Novartis AG

Physician Views: How comfortable are doctors with the commercial use of gene therapy?

  • Biological Therapy
  • Gene Therapy
  • Healthcare
  • Europe
  • United States

Introduction to Gene Therapy ##. ## History of Gene Therapy ##. ## Vectors of Gene Therapy ##. ##. ## Viral Vectors ##. ##. ## Non-Viral Vectors ##. ## Gene Therapy Protocol ##.

  • Biological Therapy
  • Gene Therapy
  • World

Additionally, increasing focus on R& D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

  • Biological Therapy
  • Drug Delivery
  • Gene Therapy
  • Nanotechnology-Based Drug Delivery
  • Forecast
  • Definition of Gene Therapy
  • Pipeline Gene Therapies by Vector
  • Biological Therapy
  • Biotechnology
  • Gene Therapy
  • 12.6.3. MANUFACTURING CAPABILITIES
  • 12.11.5.1. MEMORIAL SLOAN KETTERING CANCER CENTRE
  • Gene Therapy
  • United States
  • Cellectis S.A.
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.

How familiar they are with gene therapy What they perceive to be the key benefits of gene therapy?

  • Biological Therapy
  • Cardiovascular Drug
  • Gene Therapy
  • Health Care Provider
  • Therapy
  • GENE THERAPY
  • GENE THERAPY PIPELINE
  • Gene Therapy
  • Bioheart, Inc.
  • Celladon Corporation
  • GlaxoSmithKline plc
  • Juventas Therapeutics, Inc.

Introduction to Gene Therapy ##. ## History of Gene Therapy ##. ## Vectors of Gene Therapy ##.

  • Biological Therapy
  • Cancer
  • Cancer Gene Therapy
  • Gene Therapy
  • GENE THERAPY FOR HEMATOLOGICAL DISORDERS - DRUG PROFILE
  • GENE THERAPY FOR HEMOPHILIA B - DRUG PROFILE
  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.
  • Gene Therapy for Sickle Cell Disease
  • Gene Therapy to Activate Dysferlin for Dysferlinopathies
  • Biological Therapy
  • Gene Therapy
  • World
  • Product Initiative
  • Selecta Biosciences, Inc.
  • GENE THERAPY TO ACTIVATE FRATAXIN FOR FRIEDRICH'S ATAXIA - DRUG PROFILE
  • GENE THERAPY TO ACTIVATE FRATAXIN FOR FRIEDREICH'S ATAXIA - DRUG PROFILE
  • Gene Therapy
  • Therapy
  • United States
  • World
  • Product Initiative
  • GENE THERAPY TO ACTIVATE GLUCURONOSYLTRANSFERASE FOR CRIGLER-NAJJAR SYNDROME - DRUG PROFILE
  • GENE THERAPY TO ACTIVATE UGT1A1 FOR CRIGLER-NAJJAR SYNDROME - DRUG PROFILE
  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • Promethera Biosciences S.A.
  • Gene Therapy to Activate Glucuronosyltransferase for Crigler-Najjar Syndrome
  • GENE THERAPY TO ACTIVATE GLUCURONOSYLTRANSFERASE FOR CRIGLER-NAJJAR SYNDROME - DRUG PROFILE
  • Biological Therapy
  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • GENE THERAPY FOR HEMATOLOGICAL DISORDERS - DRUG PROFILE
  • GENE THERAPY TO ACTIVATE FACTOR VIII FOR HEMOPHILIA A - DRUG PROFILE
  • Blood Disease
  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • LABORATORIOS DEL DR ESTEVE SA
  • STEM CELL THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE IIIA - DRUG PROFILE
  • Gene Therapy
  • United States
  • World
  • Product Initiative
  • Abeona Therapeutics, Inc.
  • R&D Progress Research and Development Brief
  • R&D Progress Research and Development Brief
  • Gene Therapy
  • Therapy
  • United States
  • World
  • Product Initiative